| Ralph Ascione, CRNA | |
|
12605 E 16th Ave, Aurora, CO 80045-2545 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Ralph Ascione |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467782482 | NPI | - | NPPES |
| 51451573 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 123411 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uchealth Highlands Ranch Hospital | Highlands ranch, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
The Global Network for Neglected Tropical Diseases' "End The Neglect" blog reports on the Brazilian Ministry of Health's launch of "a public health campaign to diagnose and treat soil-transmitted helminths (or intestinal parasites) and leprosy in school-aged children" and says it will feature stories related to the fight against NTDs in Brazil over the coming days.
Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life.
New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect.
The first Quality in Care (QiC) Hepatitis C programme is now open for entry to teams and individuals working within the field of hepatitis C.
› Verified 9 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
The Global Network for Neglected Tropical Diseases' "End The Neglect" blog reports on the Brazilian Ministry of Health's launch of "a public health campaign to diagnose and treat soil-transmitted helminths (or intestinal parasites) and leprosy in school-aged children" and says it will feature stories related to the fight against NTDs in Brazil over the coming days.
Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life.
New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect.
The first Quality in Care (QiC) Hepatitis C programme is now open for entry to teams and individuals working within the field of hepatitis C.
› Verified 9 days ago
| Entity Name | Monarch Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396774519 PECOS PAC ID: 0941293708 Enrollment ID: O20040407000036 |
News Archive
The Global Network for Neglected Tropical Diseases' "End The Neglect" blog reports on the Brazilian Ministry of Health's launch of "a public health campaign to diagnose and treat soil-transmitted helminths (or intestinal parasites) and leprosy in school-aged children" and says it will feature stories related to the fight against NTDs in Brazil over the coming days.
Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life.
New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect.
The first Quality in Care (QiC) Hepatitis C programme is now open for entry to teams and individuals working within the field of hepatitis C.
› Verified 9 days ago
| Entity Name | Us Anesthesia Partners Of Colorado Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922365782 PECOS PAC ID: 6002072055 Enrollment ID: O20120725000032 |
News Archive
The Global Network for Neglected Tropical Diseases' "End The Neglect" blog reports on the Brazilian Ministry of Health's launch of "a public health campaign to diagnose and treat soil-transmitted helminths (or intestinal parasites) and leprosy in school-aged children" and says it will feature stories related to the fight against NTDs in Brazil over the coming days.
Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life.
New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect.
The first Quality in Care (QiC) Hepatitis C programme is now open for entry to teams and individuals working within the field of hepatitis C.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ralph Ascione, CRNA Po Box 876, Aurora, CO 80040-0876 Ph: (303) 493-7000 | Ralph Ascione, CRNA 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
The Global Network for Neglected Tropical Diseases' "End The Neglect" blog reports on the Brazilian Ministry of Health's launch of "a public health campaign to diagnose and treat soil-transmitted helminths (or intestinal parasites) and leprosy in school-aged children" and says it will feature stories related to the fight against NTDs in Brazil over the coming days.
Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life.
New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect.
The first Quality in Care (QiC) Hepatitis C programme is now open for entry to teams and individuals working within the field of hepatitis C.
› Verified 9 days ago
Laura Tierney Yost, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Mrs. Janassa Opichka, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Kathleen Manning, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jody Slebodnik Barnes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jamie E Seeley, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3000 S Jamaica Ct Ste 140, Aurora, CO 80014 Phone: 866-773-4252 Fax: 866-815-7277 | |
Emma Batchelder, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 720-848-0000 | |
Matthew T Kopp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |